PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportscolonic neoplasms
MeSH D003110 - colonic neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D015179:Colorectal neoplasms
55 Companies
26 Drugs
$
Success rate
D003110: 
Colonic neoplasms
49 Companies
6 Drugs
$
Success rate
D000083023:Colitis-associated neoplasms
0 Companies
0 Drugs
Success rate
D012811:Sigmoid neoplasms
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaFluorouracil Adrucil  1991-10-18   
Capecitabine Capecitabine Teva  2012-04-20   
Fluorouracil Fluorouracil  2000-01-27   
Irinotecan Irinotecan  2008-02-27   
Novast LaboratoriesFluorouracil Fluorouracil  2019-12-12   
Irinotecan Irinotecan  2017-05-26   
Taro PharmaceuticalFluorouracil Fluorouracil  2003-11-05   
Rising PharmaceuticalsFluorouracil Fluorouracil  2015-04-20   
Johnson & JohnsonLevamisole Ergamisol  1990-06-18   
SandozFluorouracil Fluorouracil  2011-05-02   
Irinotecan Irinotecan  2008-02-27   
Bausch Health CompaniesFluorouracil Carac  2000-10-27   
Fluorouracil Efudex  1982-01-01   
Dr Reddys LaboratoriesFluorouracil Fluorouracil  2008-04-11   
Sun Pharmaceutical IndustriesCapecitabine Capecitabine SUN  2013-06-21   
Irinotecan Irinotecan  2008-04-21   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
72%
86/120
Phase 2
22%
32/146
Phase 3
40%
20/50
Approved: 6Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Capecitabine
Johnson & Johnson
Bevifimod,
Mk3475
Bausch Health Companies
Fluorouracil
Pharmacia & Upjohn
Fluorouracil
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use